<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Qu H</submitter><funding>Fundamental Research Funds for the Central Universities</funding><funding>NIAAA NIH HHS</funding><funding>National High-tech Research and Development Program</funding><pagination>992096</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9939899</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13</volume><pubmed_abstract>&lt;h4>Background and objective&lt;/h4>For patients with advanced colorectal liver metastases (CRLMs) receiving first-line anti-angiogenic therapy, an accurate, rapid and noninvasive indicator is urgently needed to predict its efficacy. In previous studies, dynamic radiomics predicted more accurately than conventional radiomics. Therefore, it is necessary to establish a dynamic radiomics efficacy prediction model for antiangiogenic therapy to provide more accurate guidance for clinical diagnosis and treatment decisions.&lt;h4>Methods&lt;/h4>In this study, we use dynamic radiomics feature extraction method that extracts static features using tomographic images of different sequences of the same patient and then quantifies them into new dynamic features for the prediction of treatmentefficacy. In this r</pubmed_abstract><journal>Frontiers in oncology</journal><pubmed_title>Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases.</pubmed_title><pmcid>PMC9939899</pmcid><funding_grant_id>R01 AA022701</funding_grant_id><pubmed_authors>Zhai H</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Cui X</pubmed_authors><pubmed_authors>Qu H</pubmed_authors><pubmed_authors>Zhong H</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases.</name><description>&lt;h4>Background and objective&lt;/h4>For patients with advanced colorectal liver metastases (CRLMs) receiving first-line anti-angiogenic therapy, an accurate, rapid and noninvasive indicator is urgently needed to predict its efficacy. In previous studies, dynamic radiomics predicted more accurately than conventional radiomics. Therefore, it is necessary to establish a dynamic radiomics efficacy prediction model for antiangiogenic therapy to provide more accurate guidance for clinical diagnosis and treatment decisions.&lt;h4>Methods&lt;/h4>In this study, we use dynamic radiomics feature extraction method that extracts static features using tomographic images of different sequences of the same patient and then quantifies them into new dynamic features for the prediction of treatmentefficacy. In this r</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-04T20:09:53.395Z</modification><creation>2025-04-04T20:09:53.395Z</creation></dates><accession>S-EPMC9939899</accession><cross_references><pubmed>36814812</pubmed><doi>10.3389/fonc.2023.992096</doi></cross_references></HashMap>